Parra C, Roldán E, Rodríguez C, Pérez de Oteyza J, Oteho E, López J, Maldonado M S, García Laraña J, Muñoz A, Odriozola J, Brieva J A
Servicio de Immunología, Hospital Ramón y Cajal, Madrid.
Med Clin (Barc). 1999 Jun 12;113(1):1-5.
This study compares the immune reconstitution of total T cells, CD4 and CD8 cell subsets, activated T cells, NK cells and B cells in 66 patients who underwent allogeneic or autologous bone marrow transplantation (BMT).
PATIENTS, MATERIAL AND METHODS: The reconstitution of peripheral lymphocytes subsets was studied using two-color flow cytometry. The study group consisted of 39 patients who received allogeneic BMT compared with 27 patients who received autologous BMT. Peripheral blood was examined at different time intervals. As a measure of immune function, the response to the mitogen phytohemaglutinin (PHA) was determined.
The pattern of recovery of CD3+, CD4+ and CD8+ T cells, as well as the PHA response, was similar for each type of transplant. CD3+CD5- cells were significantly higher following autologous BMT than after allogeneic BMT and during more time. An overexpression of DR on T cells following autologous or allogeneic BMT demonstrates an increasing degree of T-lymphocyte activation. This activated T-cell subset was more stable in patients transplanted with allogeneic BM than in patients treated with autologous BM. The levels of total B cells and CD19+CD5+ B-cells were increased during 2 to 12 months following autologous MBT, remaining normal afterwards; in contrast, the levels of CD19+ lymphocytes and CD19+CD5+B-cells remained higher than normal ranges until 36 months in patients transplanted with allogeneic BM. The percentage of NK cells was significantly increased following both autologous and allogeneic BMT. The highest percentage of NK cells were detected about 2 and 6 months post-transplant in patients treated with autologous or allogeneic BM, respectively.
Allogeneic BMT appears to induce a slight delay recovery of B and NK cells in comparison to autologous BMT. In contrast, T-cells recovery was similar for each type of transplant, although a higher percentage of CD3+CD5- T cells and a faster recovery of activated CD3+DR+ cells to normal levels were observed in patients transplanted with autologous BM.
本研究比较了66例接受异基因或自体骨髓移植(BMT)患者的总T细胞、CD4和CD8细胞亚群、活化T细胞、NK细胞和B细胞的免疫重建情况。
患者、材料与方法:采用双色流式细胞术研究外周淋巴细胞亚群的重建情况。研究组包括39例接受异基因BMT的患者和27例接受自体BMT的患者。在不同时间间隔对外周血进行检测。作为免疫功能的一项指标,测定对有丝分裂原植物血凝素(PHA)的反应。
每种移植类型的CD3 +、CD4 +和CD8 + T细胞的恢复模式以及PHA反应相似。自体BMT后CD3 + CD5 -细胞在更多时间内显著高于异基因BMT后。自体或异基因BMT后T细胞上DR的过表达表明T淋巴细胞活化程度增加。这种活化的T细胞亚群在接受异基因骨髓移植的患者中比接受自体骨髓移植的患者更稳定。自体MBT后2至12个月总B细胞和CD19 + CD5 + B细胞水平升高,之后保持正常;相比之下,接受异基因骨髓移植的患者中,CD19 +淋巴细胞和CD19 + CD5 + B细胞水平在36个月前一直高于正常范围。自体和异基因BMT后NK细胞百分比均显著增加。自体或异基因骨髓移植治疗的患者分别在移植后约2个月和6个月检测到最高百分比的NK细胞。
与自体BMT相比,异基因BMT似乎会导致B细胞和NK细胞的恢复略有延迟。相比之下,每种移植类型的T细胞恢复相似,尽管在接受自体骨髓移植的患者中观察到更高百分比的CD3 + CD5 - T细胞以及活化的CD3 + DR +细胞更快恢复到正常水平。